See where your
growth lies.
Know where to invest to capture it. We help life sciences leaders size growth opportunities, identify what slows uptake and make sharper choices across markets, brands and portfolios.
Commercial judgment,
backed by analytical depth.
We combine industry experience, real-world market understanding and advanced analytics to help your team evaluate choices and carry them into commercial action.
- 01Industry
perspectiveUnderstand commercial realities - 02Market & patient
evidenceGround choices in real patterns - 03Scenario
analysisCompare the trade-offs - 04Execution
prioritiesTranslate insight into action
Commercial opportunity is rarely where the headline numbers suggest.
Where to grow, where to invest and what to change are connected decisions. Addressable demand, uptake barriers, customer potential and portfolio trade-offs determine how far a commercial strategy can go.
We help you understand those choices and prioritize the actions that could make the greatest difference.
Understand demand
Quantify the treatable, reachable population, not just the epidemiological ceiling.
Prioritize the opportunity
Identify patients, HCPs and accounts where a different action is feasible.
Shape execution
Design appropriate engagement, access and launch interventions within operating constraints.
Measure the difference
Separate incremental impact from changes that would have happened anyway.
Six practices.
One commercial perspective.
Market & Launch Intelligence
An addressable market estimate is not yet a growth strategy. Integrate epidemiology, observed care patterns, access and competitive dynamics to distinguish theoretical demand from reachable opportunity.
Patient Pathways & Uptake
A treatment funnel tells you how many patients are lost. Longitudinal episodes, referral pathways and event-level evidence help explain why, when and which barriers can be addressed.
HCP & Account Intelligence
High-volume prescribers are not always the best next investment. Combine patient mix, clinical networks, adoption behavior and engagement feasibility to reveal opportunity that conventional decile targeting overlooks.
Omnichannel & Field Excellence
Field activity, digital engagement and educational content should compete for attention only where they are relevant and permitted. Prioritize actions using response signals, capacity and clear business rules.
Measurement & Investment
A channel can generate attributed prescriptions without changing outcomes. Test the contribution of marketing levers, model saturation and carryover, and compare feasible allocations under real constraints.
Data & AI Acceleration
AI and automation are valuable when they preserve definitions, quality checks and accountability. Build repeatable data pipelines, analytical workflows and human review into commercial operations.
The analysis matters.
The decision matters more.
Finding high-likelihood patients when diagnosis codes are incomplete
A rare-disease commercial team needed a more useful view of patient opportunity than formal diagnosis codes could provide.
Flagging treatment interruption earlier in the care journey
Identifying patients at risk and understanding characteristics associated with drop-off prior to discontinuation.
Improving patient visibility by linking clinical and commercial signals
Standard real-world data understated metastatic disease and biomarker capture. Completeness needed verification.
See how different commercial choices change your growth outlook.
How could your launch outlook change with stronger access, different customer priorities or a shift in commercial investment? Explore the trade-offs in Aurelia, our interactive synthetic launch-scenario demonstration.
Explore the Aurelia simulationInteractive demonstration using synthetic assumptions, not client performance.
Illustrative annual brand initiators
Work directly with specialists who stay close to the decision.
Whether you are preparing for launch, evaluating a growth opportunity or improving in-market performance, we work alongside your team to frame the choices, build the evidence and develop practical recommendations.
Where is your next commercial decision getting stuck?
Tell us what the team needs to decide. We will discuss what evidence could change the answer.